216
Participants
Start Date
April 20, 2020
Primary Completion Date
February 16, 2021
Study Completion Date
February 24, 2021
ACE inhibitor, angiotensin receptor blocker
In patients randomized to stopping / replacing ACEI or ARB, it may be necessary to switch to another drug without direct effect on the RAS system. In patients, randomized to continuation, it may be needed to stop ACEI or ARB (e.g. hypotension with beginning sepsis) irrespective of the study.
Medical University Innsbruck, University Hospital of Internal Medicine III, Innsbruck
LMU Klinikum, Medizinische Klinik I, Munich
Medical University of Graz, Graz
Landeskrankenhaus Hall, Hall in Tirol
Medical University Innsbruck, Intensive Care and Emergency Medicine Department, Innsbruck
Medical University Innsbruck, University Hospital of Internal Medicine II, Innsbruck
Medical University Innsbruck, University Hospital of Internal Medicine IV, Innsbruck
Medical University Innsbruck, University Hospital of Internal Medicine I, Innsbruck
Medical University Innsbruck, University Hospital of Internal Medicine V, Innsbruck
Klinikum Klagenfurt, Klagenfurt
Bezirkskrankenhaus Kufstein, Kufstein
Klinikum Lienz, Lienz
Bezirkskrankenhaus St. Johann, Sankt Johann in Tirol
Bezirkskrankenhaus Schwaz, Schwaz
Krankenhaus St. Vinzenz Zams, Zams
University Hospital Aachen, Aachen
University Hospital Augsburg, Augsburg
Asklepios Stadtklinik Bad Tölz, Bad Tölz
Klinikum Dachau, Dachau
University Hospital Erlangen, Erlangen
University Hospital Essen, Essen
University of Freiburg, Freiburg im Breisgau
Klinikum Memmingen, Memmingen
LMU Klinikum, Medizinische Klinik III, Munich
LMU Klinikum, Medizinische Klinik II, Munich
LMU Klinikum, Medizinische Klinik IV, Munich
München Klinik Bogenhausen und Schwabing, Munich
Rotkreuzklinikum Munich, Munich
Krankenhaus Mühldorf, Mühldorf
Klinikum Rosenheim, Rosenheim
Krankenhaus Weiden, Weiden
Ludwig-Maximilians - University of Munich
OTHER
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
OTHER
Medical University Innsbruck
OTHER